Serum lipid levels during and after adjuvant toremifene or tamoxifen therapy for breast cancer
Authors:
- Heikki JoensuuHJHeikki Joensuu
- Kaija HolliKHKaija Holli
- Hanna OksanenHOHanna Oksanen
- Ritva ValavaaraRVRitva Valavaara
- 1 October 2000
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 63 (3) , 225-234
Abstract
Tamoxifen decreases serum cholesterol (S-cholesterol) level about 10% and low-density lipoprotein cholesterol (S-LDL) 15–20%, but in most studies it has increased serum triglyceride levels and had...Keywords
This publication has 23 references indexed in Scilit:
- Tamoxifen in the Treatment of Breast CancerNew England Journal of Medicine, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention studyAnnals of Oncology, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer.Journal of Clinical Oncology, 1995
- Effect of tamoxifen on plasma lipids and lipoproteins in postmenopausal women with breast cancerCancer, 1994
- Cardiac and Thromboembolic Morbidity Among Postmenopausal Women With Early Stage Breast Cancer in a Randomized Trial of Adjuvant TamoxifenJNCI: Journal of the National Cancer Institute, 1993
- Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee.BMJ, 1991
- Effects of Tamoxifen Therapy on Lipid and Lipoprotein Levels in Postmenopausal Patients With Node-Negative Breast CancerJNCI: Journal of the National Cancer Institute, 1990